Academic Bibliography

Mark

Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

Ans De Beuckelaer (UGent) , Charlotte Pollard (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Lien Van Hoecke (UGent) , Tom Naessens (UGent) , Vimal Kumar Udhayakumar (UGent) , Muriel Smet (UGent) , Niek Sanders (UGent) , Stefan Lienenklaus, et al.

(2016) MOLECULAR THERAPY. 24(11). p.2012-2020

Mark

Coadministration of a plasmid encoding HIV-1 Gag enhances the efficacy of cancer DNA vaccines

Laure Lambricht, Kevin Vanvarenberg, Ans De Beuckelaer (UGent) , Lien Van Hoecke (UGent) , Johan Grooten (UGent) , Bernard Ucakar, Pascale Lipnik, Niek Sanders (UGent) , Stefan Lienenklaus, Véronique Préat, et al.

(2016) MOLECULAR THERAPY. 24(9). p.1686-1696

Mark

journalArticle
A1
open access

Modulation of protein-protein interactions for the development of novel therapeutics

Ioanna Petta (UGent) , Sam Lievens (UGent) , Claude Libert (UGent) , Jan Tavernier (UGent) and Karolien De Bosscher (UGent)

(2016) MOLECULAR THERAPY. 24(4). p.707-718

Mark

Development and validation of a small single-domain antibody that effectively inhibits matrix metalloproteinase 8

Delphine Demeestere (UGent) , Eline Dejonckheere (UGent) , Sophie Steeland (UGent) , Paco Hulpiau (UGent) , Jurgen Haustraete (UGent) , Nick Devoogdt, Rielana Wichert, Christoph Becker-Pauly, Elien Van Wonterghem (UGent) , Sylviane Dewaele (UGent) , et al.

(2016) MOLECULAR THERAPY. 24(5). p.890-902

Mark

journalArticle
A1
open access

Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional cis-regulatory motifs that enable efficient cardiac gene therapy

Melvin Y Rincon, Shilpita Sarcar, Dina Danso-Abeam, Marleen Keyaerts, Janka Matrai, Ermira Samara-Kuko, Abel Acosta-Sanchez, Takis Athanasopoulos, George Dickson, Tony Lahoutte, et al.

(2015) MOLECULAR THERAPY. 23(1). p.43-52

Mark

journalArticle
A1
open access

Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates

Marinee K Chuah, Inge Petrus, Pieter De Bleser (UGent) , Caroline Le Guiner, Gwladys Gernoux, Oumeya Adjali, Nisha Nair, Jessica Willems, Hanneke Evens, Melvin Y Rincon, et al.

(2014) MOLECULAR THERAPY. 22(9). p.1605-1613

Mark

Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model

Wouter Van Overbeke (UGent) , Adriaan Verhelle (UGent) , Inge Everaert (UGent) , Olivier Zwaenepoel (UGent) , Joël Vandekerckhove (UGent) , Claude Cuvelier (UGent) , Wim Derave (UGent) and Jan Gettemans (UGent)

(2014) MOLECULAR THERAPY. 22(10). p.1768-1778

Mark

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines

Charlotte Pollard (UGent) , Joanna Rejman (UGent) , Winni De Haes, Bernard Verrier, Ellen Van Gulck, Thomas Naessens (UGent) , Stefaan De Smedt (UGent) , Pieter Bogaert (UGent) , Johan Grooten (UGent) , Guido Vanham, et al.

(2013) MOLECULAR THERAPY. 21(1). p.251-259

Mark

Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses

Winni De Haes, Stefaan De Koker (UGent) , Charlotte Pollard (UGent) , Derek Atkinson, Erika Vlieghe, Jessy Hoste, Joanna Rejman (UGent) , Stefaan De Smedt (UGent) , Johan Grooten (UGent) , Guido Vanham, et al.

(2010) MOLECULAR THERAPY. 18(7). p.1408-1416

Mark

journalArticle
A1
open access

The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls

Dries Vercauteren (UGent) , Roosmarijn Vandenbroucke (UGent) , Arwyn T Jones, Joanna Rejman (UGent) , Jo Demeester (UGent) , Stefaan De Smedt (UGent) , Niek Sanders (UGent) and Kevin Braeckmans (UGent)

(2010) MOLECULAR THERAPY. 18(3). p.561-569

Academic Bibliography

Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

Coadministration of a plasmid encoding HIV-1 Gag enhances the efficacy of cancer DNA vaccines

Modulation of protein-protein interactions for the development of novel therapeutics

Development and validation of a small single-domain antibody that effectively inhibits matrix metalloproteinase 8

Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional cis-regulatory motifs that enable efficient cardiac gene therapy

Liver-specific transcriptional modules identified by genome-wide in silico analysis enable efficient gene therapy in mice and non-human primates

Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model

Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines

Polyelectrolyte capsules-containing HIV-1 p24 and poly I:C modulate dendritic cells to stimulate HIV-1-specific immune responses

The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls

Contents

Support

Contact